Design and Analysis of Clinical Trials with Time-to-Event Endpoints: 31 (Chapman & Hall/CRC Biostatistics Series) - Image 1

£78.54

CRC Press Design and Analysis of Clinical Trials with Time-to-Event Endpoints: 31 (Chapman & Hall/CRC Biostatistics Series)

Name: Design and Analysis of Clinical Trials with Time-to-Event Endpoints: 31 (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 78.54 GBP
Availability: InStock

Pharmacy - Dispensing

This is the usual price. Wait for it to drop, or tell us your number.

£79 today · usual range £0–£0 · best ever £63

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 639 days • 639 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 639 days • 4 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £70-77 (269 days, 42.1%)

Price range: £63 - £99

Price levels: 4 price ranges over 639 days

Description

Using time-to-event analysis methodology requires careful definition of the event, censored observation, provision of adequate follow-up, number of events, and independence or "noninformativeness" of the censoring mechanisms relative to the event. Design and Analysis of Clinical Trials with Time-to-Event Endpoints provides a thorough presentation of the design, monitoring, analysis, and interpretation of clinical trials in which time-to-event is of critical interest. After reviewing time-to-event endpoint methodology, clinical trial issues, and the design and monitoring of clinical trials, the book focuses on inferential analysis methods, including parametric, semiparametric, categorical, and Bayesian methods; an alternative to the Cox model for small samples; and estimation and testing for change in hazard. It then presents descriptive and graphical methods useful in the analysis of time-to-event endpoints. The next several chapters explore a variety of clinical trials, from analgesic, antibiotic, and antiviral trials to cardiovascular and cancer prevention, prostate cancer, astrocytoma brain tumor, and chronic myelogonous leukemia trials. The book then covers areas of drug development, medical practice, and safety assessment. It concludes with the design and analysis of clinical trials of animals required by the FDA for new drug applications. Drawing on the expert contributors’ experiences working in biomedical research and clinical drug development, this comprehensive resource covers an array of time-to-event methods and explores an assortment of real-world applications.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 1420066390
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 23 April 2009
Listed Since: 01 June 2007

Barcode

No barcode data available

CRC Press Design and Analysis of Clinical Trials with Time-to-Event Endpoints: 31 (Chapman & Hall/CRC Biostatistics Series)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Statistical Design, Monitoring, and Analysis of Clinical Trials: Principles and Methods (Chapman & Hall/CRC Biostatistics Series)

Design and Analysis of Clinical Trials: Concept and Methodologies (Wiley Series in Probability and Statistics)

Clinical Trial Biostatistics and Biopharmaceutical Applications

Sample Size Calculations in Clinical Research (Chapman & Hall/CRC Biostatistics Series)

Success Probability Estimation with Applications to Clinical Trials

Springer Modern Clinical Trial Analysis - Cancer Research Book

Exploring Medical Statistics: Biostatistics, Clinical Trials, and Epidemiology

Model-Assisted Bayesian Designs for Dose Finding and Optimization: Methods and Applications (Chapman & Hall/CRC Biostatistics Series)

Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Introduction to Statistical Methods for Clinical Trials (Chapman & Hall/CRC Texts in Statistical Science)

Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Clinical Trials: A Methodologic Perspective (WILEY SERIES IN PROB & STATISTICS/see 1345/6,6214/5)

Group Sequential and Adaptive Methods for Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Fundamentals of Clinical Trials

Modern Approaches to Clinical Trials Using SAS: Classical, Adaptive, and Bayesia: Classical, Adaptive, and Bayesian Methods

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Design and Analysis of Pragmatic Trials (Chapman & Hall/CRC Biostatistics Series)

Methods and Applications of Statistics in Clinical Trials, Volume 2: Planning, Analysis, and Inferential Methods

Recent Advances in Clinical Trial Design and Analysis: 75 (Cancer Treatment and Research, 75)

Randomised Clinical Trials: Design, Practice and Reporting

Estimands, Estimators and Sensitivity Analysis in Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Interval-Censored Time-to-Event Data: Methods and Applications (Chapman & Hall/CRC Biostatistics Series)

Interval-Censored Time-to-Event Data: Methods and Applications: 52 (Chapman & Hall/CRC Biostatistics Series)

Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines